Pacific Biosciences of California, Inc.
PACB· Nasdaq
Released Nov 1, 2012, after the close
10-Q filed Nov 1, 2012, 32 days after period end · 0001193125-12-446102
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $2.78M | $10.52M | $220.00K |
| Net Income | -$22.73M | -$29.28M | -$40.71M |
| EPS Diluted | -$0.41 | -$0.54 | -$39.70 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR